3rd RSC / SCI / SEQT Symposium on

Medicinal Chemistry for Global Health

Wednesday-Friday, 24th-26th June 2020


GlaxoSmithKline, Tres Cantos, Madrid, Spain


Registration is open


Twitter hashtag - #MCGH20


Downloads and Links

Online registration - for payment by card
Registration form - for payment by bank transfer or cheque

Second announcement

First announcement

Bursary application form - closing date is 8th May


Oral abstract template - final closing date is 24th April   

Early submission is encouraged because spaces are limited and speaker slots are being allocated on a case-by-case basis.


Venue location weblink - using Bing maps


RSC website

SCI website

SEQT website



Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.

This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation.


Who should attend?
Bringing together leading exponents for an exciting spread of themed sessions, the meeting will appeal to anyone with an interest in drug discovery and medicinal chemistry. And with great opportunities for collaborative academic-industrial partnerships and open innovation drug discovery programmes, researchers from both sectors will benefit from the networking opportunities that the meeting will also offer.


Call for Abstracts

Abstracts are invited for short oral presentations, and the final closing date for abstract submission is 24th April.    Early submission is encouraged because spaces are limited and speaker slots are being allocated on a case-by-case basis.


Please download an abstract template here.


Confirmed Speakers

Antibiotic destruction by its target and the limits of irreversible inhibition

Luiz Carvalho, Francis Crick Institute, UK

KRS – a novel target for TB, exploited using structure-based drug design

Laura Cleghorn, Drug Discovery Unit, University of Dundee, UK

Novel oxazolidinone-class protein synthesis inhibitors with improved safety profiles

Brendan M Crowley, MSD, USA

NTM drug discovery at CDI

Thomas Dick, Hackensack Meridian Health, US

Pharmacological interventions for the treatment of enteric bacteria

Elena Fernández Alvaro, GlaxoSmithKline, ES

Identification of novel antimalarial chemopreventive therapies

María de Gracia Gomez, GlaxoSmithKline, ES

Plasmodium autophagy evasion in the liver-stage: mechanisms and novel therapeutic opportunities

María Mota, University of Lisbon, PT


Neglected tropical disease drug discovery through a combination of lead repurposing and distributed drug discovery

Michael Pollastri, Northeastern University, US


The energy metabolism of Leishmania as a drug target

Luis Rivas, CIB-CSIC (Biological Research Center of the Spanish National Research Council), ES


Results of the proof-of-concept study for the M72/AS01E tuberculosis vaccine candidate

Lode Schuerman, GlaxoSmithKline Vaccines, BE


A proteasome inhibitors story: from bench to bedside and back again

Florencia Segal, Novartis, US


What makes a good hit and how to get there – lessons learned from NTD hit generation beyond screening
Peter Sjö, DNDi (Drugs for Neglected Diseases Initiative), CH


Driving drug discovery for global health

Peter Warner, Bill and Melinda Gates Foundation, US

Short Talks

Combination therapy for a new treatment for Chagas disease?
Carlos Montanari, University of São Paulo, Brazil

Synthesis and evaluation of cyclopeptides containing N-methyl amino acids as promising antiplasmodial agents
Gloria Serra, Universidad de la República, Uruguay

Registration, Fees and Bursaries

Registration is open


Online registration - for payment by card
Registration form - for payment by bank transfer or cheque

Registration fees until 19th March:
£215 Member of the RSC, SCI or SEQT
£286 Non-member
£88 Student* member of RSC, SCI or SEQT (undergrad or post-grad)
£143 Student* non-member (undergrad or post-grad)

Registration fees from 20th March to 21st May:
£302 Member of the RSC, SCI or SEQT
£401 Non-member
£126 Student* member of RSC, SCI or SEQT (undergrad or post-grad)
£182 Student* non-member (undergrad or post-grad)

From 22nd May:
£49 Late booking fee (payment received by the Secretariat from 22nd May onwards)


* Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Member is paid-up member of the RSC, SCI or SEQT.


Students may apply for a bursary to support registration, travel and accommodation costs, and the closing date for applications is 8th May.   Download a bursary application form here.


Student members of the SEQT will receive a direct invitation from the SEQT to apply for a bursary to attend this event.

Cancellation Policy

In the event of cancellation by 17th May 2020, 80% of the fee paid will be refunded. Cancellations must be received in writing. Refunds will not be possible after that date although substitutions are possible at any time. In the unlikely event of cancellation of the meeting, fees paid will be refunded in full.


The exhibition will be situated in a single area just outside of the lecture theatre, ensuring excellent access to delegates throughout the meeting.

The exhibition charge of £1,320 includes:

- one full delegate's attendance

- logo in rolling slides and delegate handbook

- single promotional page in printed delegate handbook


Delegate pack inserts may be booked at £200 - no more than two sheets of A4 fixed together.



Sponsors are encouraged to support this established event. Sponsorship will support the low registration fees being offered to students.  


This event is organised jointly by the:

- Royal Society of Chemistry’s Biological and Medicinal Chemistry Sector (RSC BMCS)
- Society of Chemical Industry’s Fine Chemicals Group (SCI FCG)
- Sociedad Española de Química Terapéutica (SEQT)


We are grateful to EFMC for supporting this event


Venue and Travel

Address: Trelegy Auditorium, GlaxoSmithKline, Technology Park of Madrid, C / Severo Ochoa 2, 28760 - Tres Cantos, Madrid, Spain

Air: Madrid airport (Adolfo Suárez Madrid-Barajas) has a railway station at Terminal 4. A free shuttle bus runs from outside Terminals 1, 2 and 3 to Terminal 4.

Rail: Airport to Tres Cantos with one change at Chamartin station: less than 1 hour. Airport to Madrid Atocha central railway station: 25 minutes. Service provider is Renfe Cercanías.   Download a plan of the railway routes here.

Taxi: Airport to Tres Cantos costs about €50: 30 minutes.


Car:  A limited number of car parking spaces is available on site at GSK and these will be allocated on a "first come, first served" basis.  Please book your car parking as part of the registration process and provide your vehicle's registration number.


Venue location weblink - using Bing maps



We have held a limited number of rooms with two hotels in Tres Cantos at preferential rates as below.


HotelEurostars Madrid Foro
AddressRonda de Europa ,1 Madrid - Tres Cantos 28760
Telephone+34 918 054720
ContactLara Recio

For the first ten rooms:  €97.90

For the remaining rooms: €119 B&B


Bedroom on bed and breakfast basis

To bookContact Lara Recio direct by e-mail, using the booking code “MCGH June 2020”.
ReleaseAny bedrooms not booked will be released on 21st May
HotelExe Tres Cantos
AddressPlaza de la Estación 2 Madrid, Tres Cantos 28760
Telephone+34 918 044837
ContactLoreto Vicente
Rates€128 (Tue and Wed), €113 (Thu)
BasisBedroom on bed and breakfast basis
To bookContact Loreto Vicente direct by e-mail, using the booking code “MCGH June 2020”. The hotel will collect your card details in order to hold your reservation.
ReleaseAny bedrooms not booked will be released on 21st May



Organising Committee

Dave AlkerIndependent Consultant
Mónica Cacho-IzquierdoGlaxoSmithKline
Félix CalderónGlaxoSmithKline
Liam CoxUniversity of Birmingham
José FiandorGlaxoSmithKline
Caroline Low (chair)Independent Consultant
Maria Marco-MartinGlaxoSmithKline
Ana Rosa Merino-NietoGlaxoSmithKline
Cristina RamosGlaxoSmithKline
Andrew StachulskiUniversity of Liverpool


Secretariat Contact

Maggi Churchouse Events, 3 East Barn, Market Weston Road, Thelnetham, Diss IP22 1JJ, UK

E-mail Maggi Churchouse

Telephone: +44 (0)1359 221004


Registration is open

Link to return to the RSC BMCS index page